| Original language | English (US) |
|---|---|
| Pages (from-to) | 2048-2050 |
| Number of pages | 3 |
| Journal | JACC: Cardiovascular Imaging |
| Volume | 13 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2020 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Impact of Agreement and Discrepancies in Interpretations of Stress Echocardiography : Insights From the PROMISE Trial. / Klassen, Sheila L.; Picard, Michael H.; Hill, Larry; Alhanti, Brooke; Pellikka, Patricia A.; Coles, Adrian; Duckworth, Michelle; Hoffmann, Udo; Douglas, Pamela S.
In: JACC: Cardiovascular Imaging, Vol. 13, No. 9, 09.2020, p. 2048-2050.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Impact of Agreement and Discrepancies in Interpretations of Stress Echocardiography
T2 - Insights From the PROMISE Trial
AU - Klassen, Sheila L.
AU - Picard, Michael H.
AU - Hill, Larry
AU - Alhanti, Brooke
AU - Pellikka, Patricia A.
AU - Coles, Adrian
AU - Duckworth, Michelle
AU - Hoffmann, Udo
AU - Douglas, Pamela S.
N1 - Funding Information: Please note: The PROMISE trial was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (R01HL098237, R01HL098236, R01HL098305, and R01HL098235). Dr. Hoffmann has received grants and support on behalf of his institution from KOWA, MedImmune, HeartFlow, Duke University (Abbott), Oregon Health & Science University (AHA, 13FTF16450001), Columbia University (National Institutes of Health [NIH], 5R01-HL109711), NIH/NHLBI 5K24HL113128, NIH/NHLBI 5T32HL076136, NIH/NHLBI 5U01HL123339, and consulting fees from Abbott, Duke University (NIH), and Recor Medical. Dr. Douglas has received research support from HeartFlow to her institution. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: The PROMISE trial was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (R01HL098237, R01HL098236, R01HL098305, and R01HL098235). Dr. Hoffmann has received grants and support on behalf of his institution from KOWA, MedImmune, HeartFlow, Duke University (Abbott), Oregon Health & Science University (AHA, 13FTF16450001), Columbia University (National Institutes of Health [NIH], 5R01-HL109711), NIH/NHLBI 5K24HL113128, NIH/NHLBI 5T32HL076136, NIH/NHLBI 5U01HL123339, and consulting fees from Abbott, Duke University (NIH), and Recor Medical. Dr. Douglas has received research support from HeartFlow to her institution. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2020/9
Y1 - 2020/9
UR - http://www.scopus.com/inward/record.url?scp=85085312778&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085312778&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2020.03.011
DO - 10.1016/j.jcmg.2020.03.011
M3 - Letter
C2 - 32417326
AN - SCOPUS:85085312778
VL - 13
SP - 2048
EP - 2050
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
SN - 1936-878X
IS - 9
ER -